Harshal Nandurkar

Projects

Projects per year 2000 2000 2017 2018 2019 2026

• 2 Active
• 14 Finished

Projects per year

Search results

• Finished

  RECIPE: Randomised controlled trial (RCT) of ROTEM-guided blood component administration versus standard of care in patients with cirrhosis and coagulopathy undergoing invasive procedures.

  Majeed, A. (Primary Chief Investigator (PCI)), Janko, N. E. (Chief Investigator (CI)), Roberts, S. (Chief Investigator (CI)), Kemp, W. (Chief Investigator (CI)), Nandurkar, H. (Chief Investigator (CI)) & Gow, P. J. (Chief Investigator (CI))

  5/12/19 → 20/12/24

  Project: Research

• Investigation of Thrombosis in Extracorporeal Membrane Oxygenation Drainage Cannulas

  Kaye, D. (Primary Chief Investigator (PCI)), Gregory, S. (Chief Investigator (CI)), Pellegrino, V. (Chief Investigator (CI)), Soria, J. (Chief Investigator (CI)), Steinseifer, U. (Chief Investigator (CI)), Salamonsen, R. (Chief Investigator (CI)), Nandurkar, H. (Chief Investigator (CI)), Pinar, I. (Chief Investigator (CI)) & Liao, S. (Chief Investigator (CI))

  14/01/19 → 13/01/22

  Project: Research

• Development of a Microfluidic Blood Platelet Analyser

  Nesbitt, W. (Primary Chief Investigator (PCI)), Mitchell, A. A. (Chief Investigator (CI)), Nandurkar, H. (Chief Investigator (CI)), Hamilton, J. (Chief Investigator (CI)), Thompson, P. (Chief Investigator (CI)), Tran, H. (Chief Investigator (CI)), Elliott, S. (Chief Investigator (CI)) & Macfarlane, I. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/19 → 31/07/23

  Project: Research

• Targeting a novel anti-platelet mechanism for improved anti-thrombotic therapy

  Hamilton, J. (Primary Chief Investigator (PCI)), Thompson, P. (Chief Investigator (CI)), Nandurkar, H. (Chief Investigator (CI)), Andrews, R. (Chief Investigator (CI)) & Nesbitt, W. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/18 → 31/12/21

  Project: Research

• Targeted delivery of CD39 to the ischaemic brain improves outcomes in stroke

  Nandurkar, H. (Primary Chief Investigator (PCI)), Medcalf, R. (Chief Investigator (CI)), Wong, C. (Associate Investigator (AI)) & Robson, S. C. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/18 → 31/12/21

  Project: Research

• Proof-of-concept studies for a novel anti-thrombotic agent

  Hamilton, J. (Primary Chief Investigator (PCI)), Sleeman, M. (Chief Investigator (CI)) & Nandurkar, H. (Chief Investigator (CI))

  1/01/18 → 31/12/20

  Project: Research

• Evaluation of targeted immunotherapeutic agents in reducing haemophilia arthropathy in a murine model of haemophilia.

  Nandurkar, H. (Primary Chief Investigator (PCI)), Tran, H. (Chief Investigator (CI)) & Hauw, W. S. W. (Chief Investigator (CI))

  Haemophilia Foundation Australia Inc

  3/04/17 → 2/04/18

  Project: Research

• Delivering CD39 to the inured brain as a novel way to improve outcome after ischemic stroke

  Nandurkar, H. (Primary Chief Investigator (PCI)), Sashindranath, M. (Chief Investigator (CI)), Sturgeon, S. (Chief Investigator (CI)), Nesbitt, W. (Chief Investigator (CI)) & Willcox, A. (Chief Investigator (CI))

  1/02/17 → 31/01/18

  Project: Research

• Development of a novel drug to treat liver veno-occlusive disease: characterisation and pre-clinical testing

  Nandurkar, H. (Primary Chief Investigator (PCI)), Sashindranath, M. (Chief Investigator (CI)), Sturgeon, S. (Chief Investigator (CI)) & Willcox, A. (Associate Investigator (AI))

  9/01/17 → 1/03/18

  Project: Research

• Fluorescence and internal reflection system to develop lab-on-chip devices

  Nandurkar, H. (Primary Chief Investigator (PCI)), Medcalf, R. (Chief Investigator (CI)), Nesbitt, W. (Chief Investigator (CI)), Rosengarten, G. (Chief Investigator (CI)), Tovar-Lopez, F. (Chief Investigator (CI)) & Karlheinz, P. (Partner Investigator (PI))

  ARC - Australian Research Council, Monash University, RMIT University, Baker Heart and Diabetes Institute

  1/01/16 → 29/09/16

  Project: Research

• VCAM-targeted delivery of recombinant CD39 to the endothelium is antithrombotic, antiinflammatory and ameliorates ischaemia reperfusion injury

  Nandurkar, H. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/15 → 31/12/18

  Project: Research

• MTMR4, a regulator of PtdIns(3)P

  Mitchell, C. (Primary Chief Investigator (PCI)) & Nandurkar, H. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  5/01/09 → 31/12/11

  Project: Research

• The Characterisation of a 108 Kda Inositol Polyphosphate 5-phosphatase: Regulator of Cell Death

  Mitchell, C. (Primary Chief Investigator (PCI)) & Nandurkar, H. (Chief Investigator (CI))

  Cancer Council Victoria

  1/01/01 → 31/12/03

  Project: Research

• Regulation of Cell Growth and Differentiation by a Novel Phosphoinositide 3-phosphatase

  Nandurkar, H. (Primary Chief Investigator (PCI)) & Mitchell, C. (Chief Investigator (CI))

  ARC - Australian Research Council

  1/01/00 → 31/12/00

  Project: Research